This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Mengqi Hu: Innovator in Therapeutic Protein Development
Introduction
Mengqi Hu is a prominent inventor based in White Plains, NY (US). She has made significant contributions to the field of therapeutic protein development. Her innovative work focuses on the identification and quantification of host cell protein impurities, which is crucial for the advancement of biopharmaceuticals.
Latest Patents
Mengqi Hu holds a patent titled "Unbiased and high-throughput identification and quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development." This patent outlines methods for identifying and quantifying host cell proteins (HCPs) using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The invention aims to provide unbiased identification and sensitive quantitation of HCPs, enhancing the development of therapeutic proteins.
Career Highlights
Mengqi Hu is currently employed at Regeneron Pharmaceuticals, Inc., where she applies her expertise in therapeutic protein development. Her work is instrumental in ensuring the quality and efficacy of biopharmaceutical products.
Collaborations
Some of her notable coworkers include Yu Huang and Haibo Qiu, who collaborate with her on various projects related to therapeutic protein development.
Conclusion
Mengqi Hu's contributions to the field of therapeutic protein development through her innovative patent and work at Regeneron Pharmaceuticals, Inc. highlight her role as a key inventor in the industry. Her efforts continue to advance the science of biopharmaceuticals, ensuring safer and more effective treatments for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
